跳到正文
原文
MedPage Today·· 2026-10-08精选AI 评分69

FDA 警告 Amazon 销售未获批疱疹治疗产品

FDA Warns Amazon Over Herpes Treatments

AI 导读

FDA 向 Amazon CEO Andy Jassy 发送警告函,称其在售的多种生殖器疱疹相关产品属于未批准新药,可能构成严重公共卫生隐患。这些产品包括 FemiClear、Hclear for him、HerpCare Ointment 等,FDA 指出患者若依赖它们可能延误及时、恰当的医疗,增加不孕、败血症和死亡等严重并发症的风险,甚至因错误认为已治愈而无意中传染伴侣。

推荐理由

FDA 警告函点明在售疱疹产品被认定为未批准新药,并可能让使用者延误正规医疗而加重风险。

正文 · 原文

— Products pose "serious public health concern," agency said

by Rachael Robertson, Enterprise & Investigative Writer, MedPage Today

October 7, 2026 • 2 min read

The FDA hit Amazon with a warning letter for selling unapproved herpes treatments.

In July, the agency purchased several of the herpes products available on Amazon's website and found numerous violations, including that these products are considered unapproved new drugs, the agency said in the warning letter.

This poses "a serious public health concern," the agency wrote, since people relying on these products "may forgo timely, appropriate medical care, increasing their risk of severe complications such as infertility, sepsis, and death."

Moreover, "a false sense of having been adequately treated may lead individuals to unknowingly transmit infections to their partners," the letter stated.

The unapproved products include "FemiClear," "Hclear for him," "HerpCare Ointment," "HerpCare Spray," "Herstat GST," "Genital Herpes Ointment," "RoyceDerm Herpes Relief Cream," "Terragen HG Formula," and "Genital Herpes Intimate Wash."

Several of these products are listed as homeopathic, but FDA noted that they are still considered drugs and aren't exempt from agency drug approval requirements. Plus, many include lemongrass, which is not listed as an active ingredient in Homeopathic Pharmacopeia of the United States (HPUS), and therefore the products do not meet FDA's definition of a homeopathic drug product.

FDA noted that it hasn't approved any over-the-counter treatments for any sexually transmitted infection.

"The public should not be subject to these quack medicines," Jeffrey Klausner, MD, MPH, founder and president of the non-profit Herpes Cure Advocacy, told MedPage Today.

Klausner noted that when people see products at major retailers, they assume they're legitimate. As more people lose health insurance, patients are motivated to turn to retailers like Amazon for their health needs.

"There's a lot of unscrupulous vendors out there that put up products that don't work," he said, adding that this is a common issue with infectious disease and sexually transmitted infections. Herpes is one of the most common lifelong infections, with millions of Americans seeking treatment. With these unapproved products on the market, patients waste their money and may spread herpes because they think they're becoming noninfectious, he noted.

This isn't the first time Amazon has been hit with an FDA warning letter in recent years. In 2024, FDA warned the retailer about potent chemical peel products that the agency said were too concentrated to be used safely at home without medical supervision. In 2023, it received another warning letter about energy-enhancing supplements after FDA testing revealed the products contained undeclared erectile dysfunction drugs.

"FDA oversight and compliance with applicable regulatory requirements are essential to ensuring that nonprescription medicines are safe, effective, high-quality, and appropriately labeled," Scott Furness, PhD, of the Consumer Healthcare Products Association, told MedPage Today. He said that the organization "supports strong enforcement of these standards to protect consumers and maintain confidence in the products they rely on to manage their health."

The warning letter, sent by FDA's Center for Drug Evaluation and Research on Oct. 1, is addressed to Amazon's CEO Andy Jassy and requests a written response within 15 business days detailing the corrective and preventive steps Amazon has taken.

来源:MedPage Today · medpagetoday.com